Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
Globe Newswire12-06-2023, 13:00
Curia Appoints Gerald Auer as Chief Financial Officer 15-12-2023, 21:00